These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32997587)

  • 1. Empirical weighted Bayesian tolerance intervals.
    Tran H
    J Biopharm Stat; 2021 Mar; 31(2):180-190. PubMed ID: 32997587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies.
    Seide SE; Röver C; Friede T
    BMC Med Res Methodol; 2019 Jan; 19(1):16. PubMed ID: 30634920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributes.
    Montes RO
    Pharm Stat; 2024; 23(2):168-184. PubMed ID: 37871968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequentist performances of Bayesian prediction intervals for random-effects meta-analysis.
    Hamaguchi Y; Noma H; Nagashima K; Yamada T; Furukawa TA
    Biom J; 2021 Feb; 63(2):394-405. PubMed ID: 33164247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.
    Bickel DR
    Stat Appl Genet Mol Biol; 2012 Feb; 11(3):Article 7. PubMed ID: 22499708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tolerance interval approach for assessment of agreement with left censored data.
    Choudhary PK
    J Biopharm Stat; 2007; 17(4):583-94. PubMed ID: 17613643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval estimation of a population mean using existing knowledge or data on effect sizes.
    Shen C
    Stat Methods Med Res; 2019 Jun; 28(6):1703-1715. PubMed ID: 29734870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using tolerance intervals for assessment of pharmaceutical quality.
    Dong X; Tsong Y; Shen M; Zhong J
    J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving coverage probabilities for parametric tolerance intervals via bootstrap calibration.
    Zou Y; Young DS
    Stat Med; 2020 Jul; 39(16):2152-2166. PubMed ID: 32249974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing methods for calculating confidence intervals for vaccine efficacy.
    Ewell M
    Stat Med; 1996 Nov 15-30; 15(21-22):2379-92. PubMed ID: 8931208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confidence intervals for rainfall dispersions using the ratio of two coefficients of variation of lognormal distributions with excess zeros.
    Yosboonruang N; Niwitpong SA; Niwitpong S
    PLoS One; 2022; 17(3):e0265875. PubMed ID: 35320313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joining forces of Bayesian and frequentist methodology: a study for inference in the presence of non-identifiability.
    Raue A; Kreutz C; Theis FJ; Timmer J
    Philos Trans A Math Phys Eng Sci; 2013 Feb; 371(1984):20110544. PubMed ID: 23277602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confidence and coverage for Bland-Altman limits of agreement and their approximate confidence intervals.
    Carkeet A; Goh YT
    Stat Methods Med Res; 2018 May; 27(5):1559-1574. PubMed ID: 27587594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When significance becomes insignificant: Effect sizes and their uncertainties in Bayesian and frequentist frameworks as an alternative approach when analyzing ecotoxicological data.
    Feckler A; Low M; Zubrod JP; Bundschuh M
    Environ Toxicol Chem; 2018 Jul; 37(7):1949-1955. PubMed ID: 29508923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Bayesian expected power via Bayesian bootstrap.
    Liu F
    Stat Med; 2018 Oct; 37(24):3471-3485. PubMed ID: 29938832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship.
    Guo B; Li Y
    BMC Med Res Methodol; 2014 Jul; 14():95. PubMed ID: 25074481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective bayesian analysis for multiple repairable systems.
    D'Andrea AME; Tomazella VLD; Aljohani HM; Ramos PL; Almeida MP; Louzada F; Verssani BAW; Gazon AB; Afify AZ
    PLoS One; 2021; 16(11):e0258581. PubMed ID: 34813589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.